79258141

Information

• Trademark
• 79258141

• Source

• Serial Number

  79258141

• Registration Number

  6055470

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  November 29, 2018
  6 years ago

• Registration Date

  May 19, 2020
  4 years ago

• Transaction Date

  May 08, 2024
  8 months ago

• Status Date

  May 19, 2020
  4 years ago

• Published for Opposition Date

  March 03, 2020
  4 years ago

• Location Date

  May 19, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  EULIN, INGRID C

• Attorney Docket Number

  2078154-0003

  Law Office Assigned Location Code

  M20

• Owners

  • Stichting Hubrecht Organoid Technology

Case File Statements

• DM0000: The mark consists of a stylized outline design of cells in shades of teal. The white inside the cell is background only and is not claimed as a feature of the mark.
• GS0051: Cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary, diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx
• CC0000: The color(s) teal is/are claimed as a feature of the mark.
• GS0011: Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes
• GS0441: Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services
• GS0421: Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine

Case File Event Statements

• 5/10/2019 - 5 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 5/9/2019 - 5 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 5/10/2019 - 5 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 5/14/2019 - 5 years ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 5/16/2019 - 5 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/17/2019 - 5 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 6/5/2019 - 5 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 6/5/2019 - 5 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 6/22/2019 - 5 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/8/2019 - 5 years ago

  10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/8/2019 - 5 years ago

  11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 8/1/2019 - 5 years ago

  12 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 12/5/2019 - 5 years ago

  13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/5/2019 - 5 years ago

  14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 12/6/2019 - 5 years ago

  15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/18/2019 - 5 years ago

  16 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/18/2019 - 5 years ago

  17 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/18/2019 - 5 years ago

  18 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/18/2019 - 5 years ago

  19 - ASSIGNED TO LIE Type: ALIE

• 12/18/2019 - 5 years ago

  20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/18/2019 - 5 years ago

  21 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 12/18/2019 - 5 years ago

  22 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 12/18/2019 - 5 years ago

  23 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 12/18/2019 - 5 years ago

  24 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 12/18/2019 - 5 years ago

  25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/1/2020 - 5 years ago

  26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/1/2020 - 5 years ago

  27 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/1/2020 - 5 years ago

  28 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/6/2020 - 5 years ago

  29 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 1/22/2020 - 4 years ago

  32 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/17/2020 - 4 years ago

  30 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 1/21/2020 - 4 years ago

  31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/22/2020 - 4 years ago

  34 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 1/22/2020 - 4 years ago

  35 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 1/22/2020 - 4 years ago

  33 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 1/22/2020 - 4 years ago

  36 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 1/24/2020 - 4 years ago

  37 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/30/2020 - 4 years ago

  38 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 2/12/2020 - 4 years ago

  40 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 2/28/2020 - 4 years ago

  42 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 2/12/2020 - 4 years ago

  39 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 2/12/2020 - 4 years ago

  41 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 3/3/2020 - 4 years ago

  44 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 3/3/2020 - 4 years ago

  43 - PUBLISHED FOR OPPOSITION Type: PUBO

• 5/19/2020 - 4 years ago

  45 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/5/2024 - 9 months ago

  50 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD

• 8/19/2020 - 4 years ago

  46 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 9/23/2020 - 4 years ago

  47 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/23/2020 - 4 years ago

  48 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 10/10/2020 - 4 years ago

  49 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/7/2024 - 8 months ago

  51 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH